Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Operating Leases (2019 - 2025)

CV Sciences' Operating Leases history spans 7 years, with the latest figure at $162000.0 for Q3 2025.

  • For Q3 2025, Operating Leases changed N/A year-over-year to $162000.0; the TTM value through Sep 2025 reached $162000.0, changed N/A, while the annual FY2024 figure was $19000.0, 67.24% down from the prior year.
  • Operating Leases for Q3 2025 was $162000.0 at CV Sciences, down from $230000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $3.3 million in Q1 2021 and bottomed at $19000.0 in Q4 2024.
  • The 5-year median for Operating Leases is $188000.0 (2022), against an average of $569666.7.
  • The largest annual shift saw Operating Leases tumbled 91.7% in 2024 before it skyrocketed 400.0% in 2025.
  • A 5-year view of Operating Leases shows it stood at $3.1 million in 2021, then tumbled by 93.96% to $188000.0 in 2022, then tumbled by 69.15% to $58000.0 in 2023, then plummeted by 67.24% to $19000.0 in 2024, then skyrocketed by 752.63% to $162000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Operating Leases are $162000.0 (Q3 2025), $230000.0 (Q2 2025), and $115000.0 (Q1 2025).